Pharmaceutical Strategies Group Launches “Total Cost of Diabetes Care” Feature for Health Plans and Employers

Pharmaceutical Strategies Group (PSG) announced the launch of a diabetes cost management tool, called “Total Cost of Diabetes Care,” designed for health plans and employers to manage the total cost of diabetes care among their users (view PSG website). Below, FENIX provides highlights from the press release as well as potential readthrough to companies like Livongo, Dario, and Onduo.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.